CPAH Insider Trading Activity and SEC Form 4 Filings
CPAH insider trading summary
No open-market insider purchases or sales of Counterpath Corp (CPAH) have been reported on SEC Form 4 in the past 12 months.
Latest CPAH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 10, 2020 | Terence H Matthews | Chairman | Buy | $500K (142,451 @ $3.51) |
| Jun 10, 2020 | Karen Bruk | 10% Owner | Buy | $500K (142,451 @ $3.51) |
| Jun 10, 2020 | Steven Bruk | Director | Buy | $500K (142,451 @ $3.51) |
| Jan 13, 2020 | Larry Timlick | Director | Sell | $72K (10,000 @ $7.18) |
| Jan 13, 2020 | Larry Timlick | Director | Sell | $6K (1,000 @ $6.13) |
| Mar 19, 2018 | Steven Bruk | Director | Buy | $323 (100 @ $3.23) |
| Mar 19, 2018 | Karen Bruk | 10% Owner | Buy | $1K (400 @ $3.12) |
| Mar 19, 2018 | Karen Bruk | 10% Owner | Buy | $321 (100 @ $3.21) |
| Mar 19, 2018 | Karen Bruk | 10% Owner | Buy | $323 (100 @ $3.23) |
| Mar 19, 2018 | Steven Bruk | Director | Buy | $642 (200 @ $3.21) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.